期刊文献+

Th1-Th2-Th17细胞因子在小鼠慢性心肌炎中的表达 被引量:6

Expressions of Th1-Th2-Th17 cytokines in mice chronic viral myocarditis
下载PDF
导出
摘要 目的:观察Th1-Th2-Th17细胞因子在小鼠慢性心肌炎(VMC)模型中的表达,探究其在慢性VMC中的作用及其意义。方法:用柯萨奇病毒B3(CVB3)建立BALB/c VMC小鼠模型,实验组(n=15)腹腔注射磷酸缓冲液(Phosphate-buffered saline,PBS)0.1 ml,含102TCID50 CVB3病毒液;对照组(n=10)腹腔注射PBS 0.1 ml,不含病毒液。在注射后的第8周,心肌HE染色观察其病理形态特征;Masson's染色法观察心肌组织纤维化程度;检测血浆中Th1-Th2-Th17细胞因子含量及心肌组织中上述细胞因子的mRNA表达情况。结果:病毒感染8周后心肌病理符合慢性VMC病理特征;与对照组比较,血浆及心肌中IL-2、IL-5、IL-10、IL-13、IL-17、IL-6、IL-22、IL-21及TGF-β均明显升高(P均<0.05)。结论:Th1-Th2-Th17细胞因子失衡导致的免疫紊乱可能在慢性VMC发病机制中起重要作用。 Objective: To investigate the expressions of Th1-Th2-Th17 cytokines in the coxsackievirus B3-induced mice chronic viral myocarditis( VMC). Methods: BALB / c mice were intraperitoneally( i. p) infected with increased CVB3 for establishing chronic VMC models. Control mice were treated with phosphate-buffered saline( PBS) i. p. Cardiac tissues were obtained 8 weeks after CVB3 injection,myocardial histopathologic changes were observed by HE and Masson staining. Th1-Th2-Th17 cytokines in plasma were detected by protein array technology,and their cardiac mRNA expressions were measured by RT-PCR. Results: Compared with the control group,levels of IL-2,IL-5,IL-10,IL-13,IL-17,IL-6,IL-22,IL-21 and TGF-β obviously increased in chronic VMC group( P all 0. 05). Conclusion: The imbalance of Th1-Th2-Th17 cytokines may play an important roles in the pathogenesis of chronic VMC.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第12期1601-1604,共4页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(No.81160032)
关键词 细胞因子 免疫紊乱 慢性心肌炎 Cytokine Immune disorders Chronic viral myocarditis
  • 相关文献

参考文献13

  • 1Yusuf S, Reddy S, Ounpuu S ,et al. Global burden of cardiovascular diseases : part | : general considerations, the epidemiologic transition, risk factors, and impact of urbanization [J].Circulation, 2001,104:2746-2753.
  • 2Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice:a model of autoimmune disease for studying immunotoxicity [J]. Methods,2007,41:118-122.
  • 3Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis[J]. Curr Opin Rheumatol,2012,24(4) :401-407.
  • 4He F, Yao H, Xiao Z, et al. Inhibition of IL-2 inducible T-cellkinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection [ J ]. Mol Immunol, 2014,59( 1 ) :30-38.
  • 5Zhang Y, ]iang L, Zhang M, et al. Galectin-9 induced myeloid suppressor cells expand regulatory T cells in an IL-lO-dependent manner in CVB3-induced acute myocarditis [ J ]. Int J Mol Sci, 2014,15 (3) :3356-3372.
  • 6Izumi T, Nishii M. Diagnostic and prognostic biomarkers in acute myocarditis. Interleukin-10 [ J]. Herz ,2012,37 (6) :627-631.
  • 7CihakovaD, Barin JG, Afanasyeva M, et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation [ J ]. Am J Pathol, 2008, 172 ( 5 ) : 1195-1208.
  • 8Fan Y, Weifeng W, Yuluan Y, et al. Treatment with a neutralizing antimurine interJeukin-17 antibody after the onset of coxsackievirus B3-induced viral myocarditis reduces myocardium inflammation [J]. Virol J,2011,8:17.
  • 9薛贻敏,伍伟锋,高梦莎,刘艳丽,孔清.白细胞介素17A对小鼠柯萨奇B3病毒性心肌炎心肌纤维化的影响[J].岭南心血管病杂志,2013,19(3):346-351. 被引量:8
  • 10Nyland JF, Fairweather D, Shirley DL, et al. Low dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice [ J ]. Toxicol Sci ,2011,125 : 134-143.

二级参考文献15

  • 1LIU P P, MASSON J W. Advances in the understanding of myocarditis [ J ]. Circulation, 2001, 104 (9) : 1076-1082.
  • 2HEYMANS S, PAUSCHINGER M, D E PALMA A, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis [ J ]. Circulation, 2006, 114 (6) : 565- 573.
  • 3IVANOV S, LINDN A. Interleukin-17 as a drug target in human disease[J]. Trends Pharmacol Sci, 2009, 30(2): 95- 103.
  • 4MI S, LI Z, YANG H Z, et al, Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF- betal-dependent and -independent mechanisms [J].J Immunol, 2011, 187(6) : 3003-3014.
  • 5FENG W, LI W, LU W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure[J].Exp Mol Pathol, 2009, 87(3) : 212-218.
  • 6FAN Y, WEIFENG W, YULUAN Y, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation[J]. Virol J, 2011, 8(1) : 17.
  • 7NAKAE S, KOMIYAMA Y, NAMBU A, et al. Antigen-specific T "cell sensitization is impaired in IL-17-deficient mice,causing suppression of allergic cellular and humoral responses[J]. Immunity, 2002, 17(3) : 375-387.
  • 8QUEREJETA R, VARO N, LOPEZ B, et al. Serum carboxy- terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease [J]. Circulation, 2000, 101 (14) : 1729-1735.
  • 9FAIRWEATHER D, ROSE N R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity [J]. Methods, 2007, 41 (1) : 118- 122.
  • 10CAFORIO A L, TONA F, BOTTARO S, et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy[J]. Autoimmunity, 2008, 41 ( 1 ) : 35- 45.

共引文献7

同被引文献69

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部